1. Zhao, Yiqiao, Tao, Zijia, Li, Lei, Zheng, Jianyi, Chen, Xiaonan. 2022. Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients. In BMC cancer, 22, 239. doi:10.1186/s12885-022-09331-8. https://pubmed.ncbi.nlm.nih.gov/35246070/
2. Bacchelli, Elena, Viggiano, Marta, Ceroni, Fabiola, Zody, Michael, Maestrini, Elena. 2023. Whole genome analysis of rare deleterious variants adds further evidence to BRSK2 and other risk genes in Autism Spectrum Disorder. In Research square, , . doi:10.21203/rs.3.rs-3468592/v1. https://pubmed.ncbi.nlm.nih.gov/37961520/
3. Liu, Tianhua, Zhang, Shu, Chen, Jie, Guo, Kun, Liu, Yinkun. 2014. The transcriptional profiling of glycogenes associated with hepatocellular carcinoma metastasis. In PloS one, 9, e107941. doi:10.1371/journal.pone.0107941. https://pubmed.ncbi.nlm.nih.gov/25232831/
4. Kizuka, Yasuhiko, Kitazume, Shinobu, Okahara, Kyohei, Sotomayor, Eduardo M, Taniguchi, Naoyuki. 2014. Epigenetic regulation of a brain-specific glycosyltransferase N-acetylglucosaminyltransferase-IX (GnT-IX) by specific chromatin modifiers. In The Journal of biological chemistry, 289, 11253-11261. doi:10.1074/jbc.M114.554311. https://pubmed.ncbi.nlm.nih.gov/24619417/